These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1337107)
1. Building a bridge between neurobiology and mental illness. Costa E J Psychiatr Res; 1992 Oct; 26(4):449-60. PubMed ID: 1337107 [TBL] [Abstract][Full Text] [Related]
2. From ion currents to genomic analysis: recent advances in GABAA receptor research. Rabow LE; Russek SJ; Farb DH Synapse; 1995 Nov; 21(3):189-274. PubMed ID: 8578436 [TBL] [Abstract][Full Text] [Related]
3. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor. Puia G; Ducic I; Vicini S; Costa E Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3620-4. PubMed ID: 1373505 [TBL] [Abstract][Full Text] [Related]
5. Antisense studies of brain GABAA receptors. Karle J Dan Med Bull; 2002 May; 49(2):130-44. PubMed ID: 12064090 [TBL] [Abstract][Full Text] [Related]
6. [GABA(A) benzodiazepine receptors and epilepsy]. Sieghart W Wien Klin Wochenschr; 1990 Mar; 102(7):197-201. PubMed ID: 2160756 [TBL] [Abstract][Full Text] [Related]
7. Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists. Klein RL; Mascia MP; Harkness PC; Hadingham KL; Whiting PJ; Harris RA J Pharmacol Exp Ther; 1995 Sep; 274(3):1484-92. PubMed ID: 7562525 [TBL] [Abstract][Full Text] [Related]
8. GABAA receptors: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors. Steiger JL; Russek SJ Pharmacol Ther; 2004 Mar; 101(3):259-81. PubMed ID: 15031002 [TBL] [Abstract][Full Text] [Related]
9. The role of GABAA receptor biogenesis, structure and function in epilepsy. Mizielinska S; Greenwood S; Connolly CN Biochem Soc Trans; 2006 Nov; 34(Pt 5):863-7. PubMed ID: 17052216 [TBL] [Abstract][Full Text] [Related]
10. From GABAA receptor diversity emerges a unified vision of GABAergic inhibition. Costa E Annu Rev Pharmacol Toxicol; 1998; 38():321-50. PubMed ID: 9597158 [TBL] [Abstract][Full Text] [Related]
11. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition. Lin Q; Peng YB; Willis WD J Neurophysiol; 1996 Jan; 75(1):109-23. PubMed ID: 8822545 [TBL] [Abstract][Full Text] [Related]
12. Regulation of GABA Gravielle MC Neurochem Int; 2018 Sep; 118():96-104. PubMed ID: 29859230 [TBL] [Abstract][Full Text] [Related]
13. GABRB2, a key player in neuropsychiatric disorders and beyond. Barki M; Xue H Gene; 2022 Jan; 809():146021. PubMed ID: 34673206 [TBL] [Abstract][Full Text] [Related]
14. GABAA receptor function in developing rat thalamic reticular neurons: whole cell recordings of GABA-mediated currents and modulation by clonazepam. Gibbs JW; Schroder GB; Coulter DA J Neurophysiol; 1996 Oct; 76(4):2568-79. PubMed ID: 8899628 [TBL] [Abstract][Full Text] [Related]
17. Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylation. Macdonald RL; Twyman RE; Ryan-Jastrow T; Angelotti TP Epilepsy Res Suppl; 1992; 9():265-77. PubMed ID: 1337441 [TBL] [Abstract][Full Text] [Related]
18. Modulatory actions of gamma aminobutyric acid (GABA) on GABA type A receptor subunit expression and function. Schousboe A; Redburn DA J Neurosci Res; 1995 May; 41(1):1-7. PubMed ID: 7674371 [TBL] [Abstract][Full Text] [Related]
19. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder. Dean B; Scarr E; McLeod M Brain Res Mol Brain Res; 2005 Aug; 138(2):145-55. PubMed ID: 15950312 [TBL] [Abstract][Full Text] [Related]
20. GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Charych EI; Liu F; Moss SJ; Brandon NJ Neuropharmacology; 2009; 57(5-6):481-95. PubMed ID: 19631671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]